Orenitram and Raudixin drug interactions - a phase IV clinical study of FDA data
Summary:
We study 17,714 people who take Orenitram (treprostinil) and Raudixin (rauwolfia serpentina). There is no drug interaction reported.
The study analyzes what interactions people have when they take Orenitram and Raudixin. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Orenitram?
Orenitram has active ingredients of treprostinil. eHealthMe is studying from 17,714 Orenitram users. Check the latest studies of Orenitram.
What is Raudixin?
Raudixin has active ingredients of rauwolfia serpentina.
No report is found.
Do you take Orenitram and Raudixin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on treprostinil and rauwolfia serpentina (the active ingredients of Orenitram and Raudixin, respectively), and Orenitram and Raudixin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Eszopiclone and Rabeprazole Sodium - 5 seconds ago
- Could Nifedipine cause Acute Circulatory Failure? - 11 seconds ago
- Could Hydroxyzine Pamoate cause Premature Baby? - 13 seconds ago
- Drug interactions of Emend and Ifosfamide - 24 seconds ago
- Weight Loss and Neck Pain - 26 seconds ago
- Could Nicotinamide cause High Blood Cholesterol? - 30 seconds ago
- Drug interactions of Zyprexa and Flurazepam Hydrochloride - 34 seconds ago
- Drug interactions of Somatuline Depot and Claritin - 36 seconds ago
- Drug interactions of Korlym and Flovent - 41 seconds ago
- Could Zantac cause Inflammatory Marker Increased? - 48 seconds ago